These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 26637328

  • 1. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S, Wang Q, Li Z, Ma X, Wu L, Ji H, Qin G.
    J Exp Clin Cancer Res; 2015 Dec 04; 34():146. PubMed ID: 26637328
    [Abstract] [Full Text] [Related]

  • 2. LDOC1 is differentially expressed in thyroid cancer and display tumor-suppressive function in papillary thyroid carcinoma.
    Zhao S, Zhao Y, Wang Q, Li Z, Ma X, Wu L, Li W, Du M, Ji H, Qin G.
    Cell Biol Int; 2020 Apr 04; 44(4):985-997. PubMed ID: 31889386
    [Abstract] [Full Text] [Related]

  • 3. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
    Zhou D, Li Z, Bai X.
    Med Sci Monit; 2017 Nov 08; 23():5321-5329. PubMed ID: 29117154
    [Abstract] [Full Text] [Related]

  • 4. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C, Wang W, Jin J, Yu Z, Xin X.
    Cell Physiol Biochem; 2017 Nov 08; 41(3):1229-1239. PubMed ID: 28268222
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M, Zhang X, Li M, Chen Q, Ye M, Liang W, Ding L, Cai H, Fu D, Lv Z.
    PLoS One; 2013 Nov 08; 8(7):e67591. PubMed ID: 23861775
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z.
    Int J Cancer; 2014 Jan 15; 134(2):257-67. PubMed ID: 23457043
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
    Meng W, Wang PS, Liu J, Xue S, Wang GM, Meng XY, Chen G.
    Oncol Rep; 2014 Dec 15; 32(6):2411-20. PubMed ID: 25231838
    [Abstract] [Full Text] [Related]

  • 9. Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation.
    Thoompumkal IJ, Rehna K, Anbarasu K, Mahalingam S.
    Cell Cycle; 2016 Dec 15; 15(23):3251-3267. PubMed ID: 27764577
    [Abstract] [Full Text] [Related]

  • 10. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB, Liu XS, Li JQ, Zhao X, Xin D, Yu D.
    J Cell Biochem; 2019 Jun 15; 120(6):10830-10846. PubMed ID: 30706537
    [Abstract] [Full Text] [Related]

  • 11. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.
    Nagasaki K, Schem C, von Kaisenberg C, Biallek M, Rösel F, Jonat W, Maass N.
    Int J Cancer; 2003 Jul 01; 105(4):454-8. PubMed ID: 12712434
    [Abstract] [Full Text] [Related]

  • 12. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.
    Feng L, Wang R, Yang Y, Shen X, Shi Q, Lian M, Ma H, Fang J.
    Life Sci; 2021 Jan 15; 265():118743. PubMed ID: 33188837
    [Abstract] [Full Text] [Related]

  • 13. Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.
    Pyo JS, Kang G, Kim DH, Chae SW, Park C, Kim K, Do SI, Lee HJ, Kim JH, Sohn JH.
    Pathol Res Pract; 2013 Apr 15; 209(4):228-32. PubMed ID: 23528368
    [Abstract] [Full Text] [Related]

  • 14. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q, Guan H, Li Y, Xiao H.
    Thyroid; 2016 Dec 15; 26(12):1733-1743. PubMed ID: 27717302
    [Abstract] [Full Text] [Related]

  • 15. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer.
    Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, He F, Moore FD, Clark OH, Ruan DT.
    J Clin Endocrinol Metab; 2011 Mar 15; 96(3):E554-65. PubMed ID: 21190978
    [Abstract] [Full Text] [Related]

  • 16. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
    Jiang J, Li Y, Jiang Z.
    Oncol Rep; 2019 Jun 15; 41(6):3281-3291. PubMed ID: 31002361
    [Abstract] [Full Text] [Related]

  • 17. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
    Ma S, Wang Q, Ma X, Wu L, Guo F, Ji H, Liu F, Zhao Y, Qin G.
    Tumour Biol; 2016 Jan 15; 37(1):989-98. PubMed ID: 26264613
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of LDOC1 in human biliary epithelial cells inhibits apoptosis through NF-κB signaling.
    Song Z, Dong R, Zhao R, Zheng S.
    J Pediatr Gastroenterol Nutr; 2013 Dec 15; 57(6):713-7. PubMed ID: 23942005
    [Abstract] [Full Text] [Related]

  • 19. JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways.
    Huang L, Cai Y, Luo Y, Xiong D, Hou Z, Lv J, Zeng F, Yang Y, Cheng X.
    Onco Targets Ther; 2019 Dec 15; 12():10501-10514. PubMed ID: 31819531
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM, Luo Y, Li DF, Wei CK, Hua KY, Song JL, Xu H, Maskey N, Fang L.
    Int J Clin Exp Pathol; 2015 Dec 15; 8(9):9889-900. PubMed ID: 26617698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.